Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Early Anti-Tumor-Necrosis-Factor Therapy for Crohn’s Disease-Related Abdominal Abscesses and Phlegmon in Children

Digestive Diseases and Sciences(2022)10.1007/s10620-022-07604-7Source: DataRank Database

Early Anti-Tumor-Necrosis-Factor Therapy for Crohn’s Disease-Related Abdominal Abscesses and Phlegmon in Children is a research paper published in Digestive Diseases and Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.34)OA: greenTopics (37)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Edwin F. de Zoeten ORCID,Jason P. Weinman ORCID,Lindsey Albenberg ORCID,Frank I. Scott ORCID,Brad D. Constant ORCID

Live enrichment

PubMed:35790702 PMC:PMC13035278 OpenAlex:https://openalex.org/W4284687076

National Institutes of Health

Grant: T32 DK067009

Pfizer

Grant: 66353149

Crohn's & Colitis Foundation

Grant: 878373

National Institutes of Health

Grant: 5T32DK067009-13

Institutional Training Grant in Pediatric Gastroenterology

FWCI

0.34

Citation Percentile

0.6%

Citation Trend

2024

2025

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13035278/

publisherhttps://link.springer.com/content/pdf/10.1007/s10620-022-07604-7.pdf

publisherhttps://link.springer.com/article/10.1007/s10620-022-07604-7/fulltext.html

journalhttps://doi.org/10.1007/s10620-022-07604-7

Fields of Study

Inflammatory Bowel DiseaseAmoebic Infections and TreatmentsOrthopedic Infections and Treatments03 medical and health sciences0302 clinical medicine

MeSH Terms

InfliximabTumor Necrosis Factor InhibitorsCellulitisCrohn DiseaseHumansNecrosisRetrospective StudiesTumor Necrosis Factor-alphaAbdominal Abscess

Keywords

MedicinePhlegmonCrohn's diseaseComplicationAdverse effectInfliximabSurgeryDiseaseInflammatory bowel diseaseInternal medicineAbscessCrohn’s DiseaseInflammatory MassAnti-tumor-necrosis-factor-alphaNecrosisAbdominal AbscessCrohn DiseaseTumor Necrosis Factor-alphaHumansTumor Necrosis Factor InhibitorsCellulitisArticleRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being